Navigation Links
FDA Reports New Risks Posed by Anemia Drugs
Date:1/3/2008

ESAs can spur faster cancer growth and earlier death, agency says

THURSDAY, Jan. 3 (HealthDay News) -- Two new studies offer further evidence of the health risks posed by the anemia drugs known as erythropoiesis-stimulating agents (ESAs), U.S. officials announced Thursday.

The studies showed that patients with breast or advanced cervical cancer who took the drugs as treatment for chemotherapy-induced anemia died sooner or had more rapid tumor growth than patients not on the drugs, U.S. Food and Drug Administration officials said in a prepared statement.

On Nov. 8, the FDA approved new "black box" warnings on labels of the three ESAs -- Aranesp, Epogen and Procrit. The warnings detailed the dangers to patients with cancer and patients with chronic kidney failure. Those dangers include heart attack, stroke, heart failure and cancer tumor growth and shortened survival, the FDA said.

The drugs had been touted as a treatment to lessen fatigue and improve quality of life among cancer, HIV and other patients with anemia, but the revised label said there was no evidence to back that claim. The label change was the fifth such change since Procrit was approved in 1989, FDA officials said.

Results of the two studies released Thursday were not among the six studies that led to the Nov. 8 label revision. Taken together, all eight studies show more rapid tumor growth or shortened survival when patients with breast, non-small cell lung, head and neck, lymphoid or cervical cancers received ESAs compared to patients who didn't get this therapy, the FDA said.

The FDA said it plans to discuss the new findings and re-examine the risks and benefits of ESAs for patients with chemotherapy-induced anemia at a public advisory committee meeting in the next few months.

"This new information further underscores the safety concerns regarding the use of ESAs in patients with cancer, which FDA addressed in previ
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement
2. UCI Medical Affiliates, Inc. Reports Fiscal Year End Results for September 30, 2007
3. The Ensign Group, Inc. Reports Third Quarter 2007 Earnings
4. HealthPartners Reports 2007 Most Cost Effective Programs Reduce Expenses by $74 Million
5. Par Pharmaceutical Reports Third-Quarter 2007 Results
6. Briggs & Riley Reports That More Travelers Focus on Health and Sanitation This Holiday Season
7. Recent Reports Underscore the Importance of Testing Supplements for Athletic Banned Substances
8. Intensive care quality of sleep improved by new drug, reports study
9. Biodel Inc. Reports Fourth Quarter and Fiscal Year 2007 Financial Results
10. IBM reports milestone in silicon nanophotonics
11. Telik Reports Positive Results From Phase 1 Dose-Escalation Study of TELINTRA Tablets in Myelodysplastic Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Reports New Risks Posed by Anemia Drugs
(Date:7/1/2015)... ... July 01, 2015 , ... ... leaders Lora Posey (Manager, National Sales Training and Development) and Chuck Corso (Associate ... (LTEN) Conference in Phoenix, AZ. LTEN brings together learning and development professionals from ...
(Date:7/1/2015)... Jackson, Tenn. (PRWEB) , ... July 01, 2015 , ... ... be held rain or shine Saturday, July 11, 2015, at 6 p.m. in Pugh ... is free and includes pony rides, a petting zoo, an Elvis impersonator, a silent ...
(Date:7/1/2015)... ... ... As if mood swings, cramps and child labor weren’t enough to endure, there ... Houston Vein Center is offering tips on the treatment options for women with leg ... often overlooked. Many women experience the tiredness, achiness, restless legs, cramps and itchiness related ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... author Lisa Stolzenberg, a Professor in FIU’s School of International and Public Affairs. ... 17 years who participated in the National Survey on Drug Use and Health, ...
(Date:7/1/2015)... ... July 01, 2015 , ... RowdMap Inc. is a proud ... paper: “Pro-actively Identifying the High-Cost Patient Population: Insights from the Health Care Transformation ... http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task Force is a group of ...
Breaking Medicine News(10 mins):Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3
... ... children,s products Yum-Yum D3 liquid, Yum-Yum GOS Syrup (prebiotic fiber syrup), Yum-Yum Zymes; and Brown ... show to be held at Sands Expo & Convention Center/The Venetian Resort Hotel Las Vegas, ... Los ...
... ... , ... 2009 -- Dr. Jan Linhart, a top-rated dentist with offices in Manhattan, claims that orthodontic work ... such as Invisalign and iBraces are extraordinarily effective at creating a beautiful ...
... , Verizon Business, Fully Managed Solution Provides Secure Foundation ... , PARIS, June 25 Invacare Corp., ... equipment, has chosen Verizon Business to deploy and manage ... Private IP solution effectively quadruples the bandwidth available to ...
... ... locum tenens physicians, Jackson & Coker has helped sponsor several "medical brigades" visiting Honduras ... ... 2009 -- Tapping the growing interest in medical volunteerism shown by many locum tenens ...
... 2009 -- Many parents worry about their child,s exposure to ... variety of personal care products, children,s toys, and medical devices. ... been associated with negative changes in endocrine function. A ... of Pediatrics examines the possibility that in utero phthalate ...
... June 24 Siemens Healthcare ( ... Miller, Chief Executive Officer (CEO) for the Workflow & Solutions ... Energy and Commerce, U.S. House of Representatives on the need ... http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ) , ...
Cached Medicine News:Health News:Jarrow Formulas, Inc. to Unveil Children's Natural Health Products at Upcoming Natural MarketPlace 2009 Show in Las Vegas 2Health News:Jarrow Formulas, Inc. to Unveil Children's Natural Health Products at Upcoming Natural MarketPlace 2009 Show in Las Vegas 3Health News:Top Dentist Issues Opinion on Health Benefits of Cutting-Edge Orthodontics 2Health News:Verizon Private IP Quadruples Network Capacity for Invacare's European Operations 2Health News:Verizon Private IP Quadruples Network Capacity for Invacare's European Operations 3Health News:Jackson & Coker Sponsors Medical Missions 2Health News:Jackson & Coker Sponsors Medical Missions 3Health News:Siemens Healthcare Testifies on Healthcare Reform and Building a Healthier America 2Health News:Siemens Healthcare Testifies on Healthcare Reform and Building a Healthier America 3
(Date:7/1/2015)... N.J. , July 1, 2015  Celsion Corporation ... today announced that Michael H. Tardugno , Chairman, ... Cantor Fitzgerald,s Inaugural Healthcare Conference on Wednesday, July 8, ... held at Le Parker Meridien Hotel located at 119 ... 10019. A copy of the presentation ...
(Date:7/1/2015)... , July 1, 2015 ... study Stationary Oxygen Concentrators Market Shares, Strategy, ... poised to achieve continuing growth as the aging population ... and other respiratory conditions where oxygen is able to ... manner. Portable devices have become affordable and support a ...
(Date:7/1/2015)... , July 1, 2015 New exchange plan ... of 2015 compared to the same time a year ... Scripts (NASDAQ: ESRX ) Exchange Pulse™ report, released ... of 2014, the number of new exchange plan enrollees ... percent in the first quarter of 2015. However, when ...
Breaking Medicine Technology:Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5
... Cardiac troponin I (cTnI) has been useful ... to Emergency Departments (ED) with chest pain. ... diagnosed when blood levels of sensitive and ... MB isoenzyme of creatine kinase (CK-MB), and ...
... Aio! 2nd generation cardiac troponin ... sensitive immunoassay providing quantitative results ... less than 18 minutes. The ... unique combination of antibodies that ...
... high-throughput immunoassay system built around the many ... the important addition of Logic Driven Incubation ... designed for optimal performance with the fastest ... assays such as the cardiac biomarkers and ...
The Acute Care myoglobin method is an in vitro diagnostic test for the measurement of myoglobin in heparinized whole blood /plasma. Myoglobin measurements can be used as an aid in diagnosing myocardi...
Medicine Products: